BCL2L1 and cancer: Fourth, H3K4me3 is enriched at the CtBP2-binding sites in human embryonic stem cells (Lee et al, 2015) and Bcl-xL overexpression increases global H3K4me3 levels in cancer cells (Choi et al., 2016).